Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · Real-Time Price · USD
0.7368
+0.0103 (1.42%)
May 23, 2025, 4:00 PM - Market closed
Xtant Medical Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 122.3 | 117.27 | 91.3 | 57.97 | 55.15 | 53.19 | Upgrade
|
| Other Revenue | - | - | - | - | 0.12 | 0.15 | Upgrade
|
| Revenue | 122.3 | 117.27 | 91.3 | 57.97 | 55.26 | 53.34 | Upgrade
|
| Revenue Growth (YoY) | 20.81% | 28.44% | 57.50% | 4.90% | 3.61% | -17.54% | Upgrade
|
| Cost of Revenue | 51.14 | 49.05 | 35.84 | 25.83 | 22.77 | 18.95 | Upgrade
|
| Gross Profit | 71.16 | 68.22 | 55.47 | 32.14 | 32.49 | 34.39 | Upgrade
|
| Selling, General & Admin | 76.4 | 77.91 | 64.29 | 37.98 | 34.87 | 34.49 | Upgrade
|
| Research & Development | 2.3 | 2.39 | 1.34 | 0.92 | 0.87 | 0.66 | Upgrade
|
| Operating Expenses | 78.7 | 80.29 | 65.63 | 38.89 | 35.74 | 35.14 | Upgrade
|
| Operating Income | -7.54 | -12.07 | -10.16 | -6.76 | -3.25 | -0.75 | Upgrade
|
| Interest Expense | -4.37 | -4.16 | -2.94 | -1.69 | -1 | -5.98 | Upgrade
|
| Interest & Investment Income | - | - | 0.15 | 0.03 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.07 | 0.01 | 0.27 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.05 | -0.03 | -0.05 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -11.9 | -16.26 | -12.73 | -8.42 | -4.25 | -6.73 | Upgrade
|
| Legal Settlements | - | - | - | - | -0.6 | - | Upgrade
|
| Other Unusual Items | - | - | 11.69 | - | - | - | Upgrade
|
| Pretax Income | -11.9 | -16.26 | -1.04 | -8.42 | -4.85 | -6.73 | Upgrade
|
| Income Tax Expense | 0.09 | 0.19 | -1.7 | 0.07 | - | 0.3 | Upgrade
|
| Net Income | -11.99 | -16.45 | 0.66 | -8.49 | -4.85 | -7.02 | Upgrade
|
| Net Income to Common | -11.99 | -16.45 | 0.66 | -8.49 | -4.85 | -7.02 | Upgrade
|
| Shares Outstanding (Basic) | 136 | 134 | 119 | 94 | 85 | 28 | Upgrade
|
| Shares Outstanding (Diluted) | 136 | 134 | 127 | 94 | 85 | 28 | Upgrade
|
| Shares Change (YoY) | 9.21% | 5.42% | 34.76% | 10.10% | 199.85% | 116.50% | Upgrade
|
| EPS (Basic) | -0.09 | -0.12 | 0.01 | -0.09 | -0.06 | -0.25 | Upgrade
|
| EPS (Diluted) | -0.09 | -0.12 | 0.01 | -0.09 | -0.06 | -0.25 | Upgrade
|
| Free Cash Flow | -9.39 | -16.01 | -10.97 | -7.11 | -1.68 | -2.28 | Upgrade
|
| Free Cash Flow Per Share | -0.07 | -0.12 | -0.09 | -0.08 | -0.02 | -0.08 | Upgrade
|
| Gross Margin | 58.18% | 58.17% | 60.75% | 55.44% | 58.79% | 64.48% | Upgrade
|
| Operating Margin | -6.17% | -10.30% | -11.13% | -11.65% | -5.89% | -1.41% | Upgrade
|
| Profit Margin | -9.80% | -14.03% | 0.72% | -14.64% | -8.77% | -13.17% | Upgrade
|
| Free Cash Flow Margin | -7.68% | -13.65% | -12.02% | -12.26% | -3.03% | -4.27% | Upgrade
|
| EBITDA | -3.25 | -7.85 | -6.98 | -5.46 | -1.92 | 1.33 | Upgrade
|
| EBITDA Margin | -2.66% | -6.69% | -7.65% | -9.42% | -3.48% | 2.49% | Upgrade
|
| D&A For EBITDA | 4.29 | 4.22 | 3.17 | 1.29 | 1.33 | 2.08 | Upgrade
|
| EBIT | -7.54 | -12.07 | -10.16 | -6.76 | -3.25 | -0.75 | Upgrade
|
| EBIT Margin | -6.17% | -10.30% | -11.13% | -11.65% | -5.89% | -1.41% | Upgrade
|
| Revenue as Reported | 122.3 | 117.27 | 91.3 | - | 55.26 | 53.34 | Upgrade
|
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.